Apollo Endosurgery (APEN) Announces CEO Transition
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Apollo Endosurgery Announces CEO Transition
February 8, 2021 9:17 AM ESTWill Transition to Accomplished Commercial and Operational Medtech Veteran Charles Mckhann
AUSTIN, TX / ACCESSWIRE / February 8, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ: APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, announced today a planned CEO change. Effective March 1, 2021, Charles (Chas) McKhann will become CEO and a member of the Board of Directors. Current CEO Todd Newton will help facilitate an effective transition to Mr. McKhann and has agreed to serve as a consultant to the... More
